NFLD – Management must enjoy playing with shareholders’ minds because today’s PR announcing the 5pm CC does not say whether the “update” includes the actual results:
“Steven A Gould, M.D., Northfield's Chairman and CEO, will host the call and provide an update on the company's pivotal Phase III clinical trial.”
The shares are probably down (17%) not because there’s a leak but rather because traders don’t like uncertainty. JMHO, FWIW
News 
Market Data 
Discover 
